Home

Световна книга за рекорди на Гинес съгласен съм Pelmel cappellini and thalassemia treatments haematologica 2017 влияние Наистина ли предимство

Tricuspid-valve regurgitant jet velocity as a risk factor for death in β- thalassemia | Haematologica
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β- thalassemia | Haematologica

Replacing the suppressed hormone: toward a better treatment for iron  overload in β-thalassemia major? | Haematologica
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica

A paradigm shift on beta-thalassaemia treatment: How will we manage this  old disease with new therapies? - ScienceDirect
A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? - ScienceDirect

IJMS | Free Full-Text | Non-Transfusion-Dependent Thalassemia: An Update on  Complications and Management
IJMS | Free Full-Text | Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management

Cureus | Thalassemia: A Review of the Challenges to the Families and  Caregivers
Cureus | Thalassemia: A Review of the Challenges to the Families and Caregivers

New treatment strategies for β-thalassemia | Encyclopedia MDPI
New treatment strategies for β-thalassemia | Encyclopedia MDPI

Non-transfusion-dependent thalassemias | Haematologica
Non-transfusion-dependent thalassemias | Haematologica

Current status of beta‐thalassemia and its treatment strategies - Ali -  2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library
Current status of beta‐thalassemia and its treatment strategies - Ali - 2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library

Cure for thalassemia major – from allogeneic hematopoietic stem cell  transplantation to gene therapy | Haematologica
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica

Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers  as Therapeutic Targets in β–Thalassemia
Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia

Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)
Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)

Frontiers | The Future of Gene Therapy for Transfusion-Dependent Beta- Thalassemia: The Power of the Lentiviral Vector for Genetically Modified  Hematopoietic Stem Cells
Frontiers | The Future of Gene Therapy for Transfusion-Dependent Beta- Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells

Thalassaemia - The Lancet
Thalassaemia - The Lancet

Cure for thalassemia major – from allogeneic hematopoietic stem cell  transplantation to gene therapy | Haematologica
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica

Gene Therapy For Beta-Thalassemia: Updated Perspectives | TACG
Gene Therapy For Beta-Thalassemia: Updated Perspectives | TACG

Quality of life in patients with β‐thalassemia: A prospective study of  transfusion‐dependent and non‐transfusion‐dependent patients in Greece,  Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of  Hematology - Wiley
Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley

Pathophysiology and treatment of patients with... | F1000Research
Pathophysiology and treatment of patients with... | F1000Research

Cure for thalassemia major – from allogeneic hematopoietic stem cell  transplantation to gene therapy | Haematologica
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica

Β-Thalassemias | NEJM
Β-Thalassemias | NEJM

Beta Thalassemia: Practice Essentials, Etiology, Epidemiology
Beta Thalassemia: Practice Essentials, Etiology, Epidemiology

Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of  Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary  Myelofibrosis
Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis

Full article: Revisiting beta thalassemia intermedia: past, present, and  future prospects
Full article: Revisiting beta thalassemia intermedia: past, present, and future prospects

Antioxidants as Complementary Medication in Thalassemia | IntechOpen
Antioxidants as Complementary Medication in Thalassemia | IntechOpen

Significance of genetic modifiers of hemoglobinopathies leading towards  precision medicine | Scientific Reports
Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports

Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th  Edition - Version 2.0) by Thalassaemia International Federation (TIF) -  Issuu
Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu

2021 update on clinical trials in β‐thalassemia - Musallam - 2021 -  American Journal of Hematology - Wiley Online Library
2021 update on clinical trials in β‐thalassemia - Musallam - 2021 - American Journal of Hematology - Wiley Online Library

Current and future alternative therapies for beta-thalassemia major -  ScienceDirect
Current and future alternative therapies for beta-thalassemia major - ScienceDirect